Bullish Case: DOV is 9.6% above its year-ago price but 16.8% below 90 days ago, yet calls traded 87% more volume than puts and the top traded option (10/16 190C, delta 0.40) sits right at spot—a bet on stabilization. Helium's PDF mass peaks near $185–195 (density ~0.176 at $185), implying downside is largely exhausted. The AI forecast is +3.0%, the term structure is in contango, and 71-year dividend-streak sentiment supports dip-buying toward $195–205 if macro stays calm.

Bearish Case: Short-term technicals are sell-dominant (RSI ~35.7, price below 190–195 moving averages) and the 90-day decline is steep. The bearish risk skew is 2% above bullish across tenors, the 11/21 market IV (27.6%) exceeds the 10/17 (23.2%), and Helium's PDF shows a fat left tail with mass out to $140–165. SPY's surface shows pronounced downside skew—any macro shock drags DOV toward $170–180.

Potential Outcomes:

1. Base (40%): Sideways drift, $180–195 by late October; falsified if ATM IV rises above 28% while spot falls.
2. Bounce (25%): +3–7% to $195–200 on oversold RSI mean-reversion and call flow; falsified by a close below $180.
3. Continued slide (20%): −4–9% to $170–178 as technicals stay sell-dominant and SPY weakens; falsified by RSI reclaiming 50.
4. Tail drop (10%): Below $170 on macro/earnings shock—10/16 130–160P IVs (36–75%) show this is priced.
5. Vol crush, flat price (5%): October IV (23.2%) compresses further with no catalyst.

Key dates: 10/16 and 11/20 expiries; Q3 earnings late October.

September 22, 2026